Advances in Anti-Metabolic Disease Treatments Targeting CD47.
Sign Up to like & getrecommendations! Published in 2022 at "Current pharmaceutical design"
DOI: 10.2174/1381612828666221006123144
Abstract: Metabolic disorders include a cluster of conditions that result from hyperglycemia, hyperlipidemia, insulin resistance, obesity, and hepatic steatosis, which cause the dysfunction of immune cells and innate cells such as macrophages, natural killer cells, vascular… read more here.
Keywords: targeting cd47; metabolic disease; metabolic diseases; cd47 ... See more keywords